Article

TLC plans to emerge from bankruptcy as private company

TLC Vision Corp. and two of its wholly owned subsidiaries, TLC Vision (USA) Corp. and TLC Management Services, are restructuring their debt through a pre-arranged Chapter 11 bankruptcy proceeding.

St. Louis, MO

-TLC Vision Corp. and two of its wholly owned subsidiaries, TLC Vision (USA) Corp. and TLC Management Services, are restructuring their debt through a pre-arranged Chapter 11 bankruptcy proceeding. As part of its plans, the company has secured $15 million in financing and will sell six refractive centers in Canada.

Operations elsewhere are continuing. TLC Laser Eye Centers are not part of the filing. The company said it expects to emerge from bankruptcy as a private company.

“After evaluating a number of strategic alternatives with our board of directors and advisers, we decided that restructuring our debt through court protection was the best way to preserve the value of our business,” said Jim Tiffany, TLC Vision president and chief executive officer. “We expect to emerge swiftly from Chapter 11 with a stronger balance sheet and able to better capitalize on our industry leadership position.”

Court documents are accessible at

http://chapter11.epiqsystems.com/tlcvision

. The company also has establishing hotlines: 877/879-5075 for callers from the United States and Canada and 503/597-7713 for international callers.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
© 2025 MJH Life Sciences

All rights reserved.